Microparticles for delivery of nucleic acid

Details for Australian Patent Application No. 2005201927 (hide)

Owner MGI PHARMA Biologics, Inc.

Inventors Hedley, Mary Lynne; Putnam, David; Lunsford, Lynn B

Agent Davies Collison Cave

Pub. Number AU-B-2005201927

Parent 40097

Filing date 6 May 2005

Wipo publication date 2 June 2005

Acceptance publication date 21 August 2008

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

19 May 2005 Complete Application Filed

2 June 2005 Application Open to Public Inspection

  Published as AU-B-2005201927

21 August 2008 Alteration of Name

  The name of the applicant has been altered to MGI PHARMA Biologics, Inc.

21 August 2008 Application Accepted

  Published as AU-B-2005201927

18 December 2008 Standard Patent Sealed

30 April 2009 Assignment Registered

  MGI PHARMA Biologics, Inc. The patent has been assigned to Eisai Corporation of North America

29 October 2009 Assignment Registered

  Eisai Corporation of North America The patent has been assigned to Eisai Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201928-Process for preparing 4-substituted 2,2,6,6-tetramethylpiperidin-N-oxy and 2,2,6,6-tetramethylpiperidin-N-hydroxy compounds

2005201926-Rock cutting machine